Alternative hypothesis for efficacy of macrolides in acute coronary syndromes

Lancet

Volumn 351, Issue 9119, 1998, Pages 1858-1859

  Martin, Donald ^b   Bursill, Jane ^b   Qui, Min Ru ^b   Breit, Samuel N ^b   Campbell, Terry ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; POTASSIUM CHANNEL; POTASSIUM ION; ROXITHROMYCIN; TETRACYCLINE;

ACUTE HEART FAILURE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; MACROPHAGE; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL;

EID: 0032551265     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78804-8     Document Type: Article

References (5)

1. 1 Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 96: 4095-103.
2. 2 Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski C, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-07.
3. 3 Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404-07.
4. 4 Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991; 87: 87-90.
5. 5 Martin DK, Bootcov MR, Campbell TJ, French PW, Breit SN. Human macrophages contain a stretch-sensitive potassium channel that is activated by adherence and cytokines. JMembrane Biol 1995; 147: 305-15.